ALLMedicine™ Helicobacter Pylori Infection Center
Research & Reviews 1,762 results
Helicobacter Osaki T, Lin Y et. al.
Jan 11th, 2022 - Helicobacter pylori infection is a well-established risk factor for gastric cancer and has been linked to other gastrointestinal diseases, including pancreatic and biliary tract cancers; however, the relevance of enterohepatic non-H. pylori helico...
Helicobacter Di Mario F, Crafa P et. al.
Jan 9th, 2022 - In the gastric mucosa, pepsinogen II (PgII) is produced/secreted by glands in the mucus-secreting antral and cardia compartments, but also by the chief cells and the oxyntic glands. Increasing PgII serum levels are associated with the whole spectr...
Helicobacter Xu C, Wu Y et. al.
Jan 9th, 2022 - Multiple studies have reported the association between Helicobacter pylori (H. pylori) infection and children's growth. The results of these studies are controversial. Our meta-analysis aimed to evaluate the association between H. pylori infection...
BMC Gastroenterology; Tanaka M, Hoteya S et. al.
Jan 8th, 2022 - Although almost all cases of gastric cancer are caused by Helicobacter pylori (HP) infection, there are some rare exceptions. Furthermore, the clinicopathological characteristics of gastric cancer may differ depending on HP infection status. This ...
Alimentary Pharmacology & Therapeutics; Dore MP, Graham DY
Jan 7th, 2022 - Modern approach to the diagnosis of Helicobacter pylori infection.|2022|Dore MP,Graham DY,|
Guidelines 7 results
Gastroenterology Shah SC, Piazuelo MB et. al.
Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...
Gastroenterology Shah SC, Iyer PG et. al.
Feb 2nd, 2021 - The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consider...
Gut Banks M, Graham D et. al.
Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...
Journal of Pediatric Gastroenterology and Nutrition; Jones NL, Koletzko S et. al.
May 26th, 2017 - Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediat...
The American Journal of Gastroenterology; Chey WD, Leontiadis GI et. al.
Jan 11th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...
Drugs 62 results see all →
Clinicaltrials.gov 63 results
Nov 30th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population,has been recognized as a main risk factor of multiple gastric pathologies,especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication i...
Nov 24th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...
Nov 18th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...
Nov 16th, 2021 - Helicobacter pylori colonizes the stomach of about half of the world's population, including about 20-30% of adults in Germany. In some cases, this colonization can lead to chronic inflammation of the gastric mucosa, which can lead to various seri...
Oct 19th, 2021 - Challenges in the treatment of Helicobacter pylori (H. pylori) include increasing antimicrobial resistance and patient's low tolerance to some regimens. Lactobacillus johnsonii (L. johnsonii) and Immunoglobulin Y (IgY) have been shown to decrease ...
News 119 results
Nov 10th, 2021 - A novel noninvasive endoscopy trial lends further support for the safety of single antiplatelet therapy after a 6-month course of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI). Results from the OP...
Oct 25th, 2021 - A new clinical practice update expert review for the diagnosis and management of atrophic gastritis (AG) from the American Gastroenterological Association focuses on cases linked to Helicobacter pylori infection or autoimmunity. Dr Shailja C. Shah...
Sep 23rd, 2021 - Testing for and treating Helicobacter pylori infection among individuals with a family history of gastric cancer could be a cost-effective strategy in the United States, according to a new model published in the journal Gastroenterology. sgame/thi.
Sep 14th, 2021 - NEW YORK (Reuters Health) - Screening for and treating Helicobacter pylori infection in those at high risk for gastric cancer is cost effective, a new modeling study shows. "This modeling study suggests that even after accounting for costs of trea...
Jim Kling, MDedge News
Jul 14th, 2021 - A network meta-analysis of current first-line dual, triple, and quadruple therapies for Helicobacter pylori infection found that vonoprazan triple therapy was most effective, while standard triple therapy of a proton pump inhibitor (PPI), amoxicil.